Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Alibin medicin AB
AB
Active
Org 5592396880
Holmfrids Väg 18
General medical practice activities · NACE 8621
Est. 2020
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 280K
-43% vs 2024
EBITDA margin
59.3%
-46% vs 2024
Equity ratio
65.8%
Financial strength
Net profit 2025
SEK 182K
-25% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
0M
-100%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 280K
-43%
EBITDA
SEK 166K
-46%
Net profit
SEK 182K
-25%
Total assets
SEK 1,3M
-5%
Equity
SEK 871K
-3%
Employees
0
—
Company information
Legal name
Alibin medicin AB
Org number
5592396880
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
31 januari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva primärvårdsmottagning samt därmed förenlig verksamhet.
Contact
Address
Holmfrids Väg 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Täby
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
873
776
609
491
280
Staff expenses
—
—
—
—
−1
EBITDA
852
620
425
306
166
Depreciation & amort.
−0
−0
−0
—
—
EBIT
852
620
425
306
166
Net financials
—
−89
70
−0
51
Profit before tax
639
420
494
306
217
Tax
−132
−96
−92
−65
−36
Net profit
507
324
402
241
182
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 134
1 428
1 375
1 397
1 323
Equity
532
654
861
898
871
Long-term debt
0
0
0
—
—
Short-term debt
389
406
146
131
85
Total debt
389
406
146
131
85
Financial ratios
5-year trend
EBITDA margin
59.3%
This company
15.8%
Market median
+275% vs market
2021
2025
Equity ratio
65.8%
This company
38.2%
Market median
+72% vs market
2021
2025
Return on equity
20.9%
This company
18.4%
Market median
+14% vs market
2021
2025
Net profit margin
64.7%
This company
8.1%
Market median
+699% vs market
2021
2025
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
2021
2025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
EC
Eva Cajsa Marcelius
Audit
Audit
2022 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JA
Jonas Albin Klarin
Deputy Board Member
2022
CM
Charlotte Marie Klarin
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Alibin medicin AB also hold positions in
0
other companies.
Person
Role here
Other companies
Eva Cajsa Marcelius
Audit
0 companies
Jonas Albin Klarin
Deputy Board Member
0 companies
Charlotte Marie Klarin
Board of Directors
0 companies